Low incidence of limb-girdle muscular dystrophy type 2C revealed by a mutation study in Japanese patients clinically diagnosed with DMD

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Okizuka, Yo ^a   Takeshima, Yasuhiro ^a   Itoh, Kyoko ^b   Zhang, Zhujun ^a   Awano, Hiroyuki ^a   Maruyama, Koichi ^c   Kumagai, Toshiyuki ^c   Yagi, Mariko ^a   Matsuo, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Aichi Welfare Center for Persons with Developmental Disabilities   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DYSTROPHIN; GAMMA SARCOGLYCAN; GENOMIC DNA; SARCOGLYCAN; SGCG PROTEIN, HUMAN;

ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE DELETION; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN TISSUE; INCIDENCE; INFANT; JAPANESE; LIMB GIRDLE MUSCULAR DYSTROPHY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; STOP CODON; ALLELE; ASIAN; GENETICS; JAPAN; MUTATION; NEWBORN;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CODON, TERMINATOR; DYSTROPHIN; EXONS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; JAPAN; MALE; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; SARCOGLYCANS;

EID: 77950411066     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-49     Document Type: Article

References (23)

1. Emery AEH. Duchenne muscular dystrophy. 1993, Oxford: Oxford University Press.
2. Bonnemann CG, Wong J, Jones KJ, Lidov HG, Feener CA, Shapiro F, Darras BT, Kunkel LM, North KN. Primary gamma-sarcoglycanopathy (LGMD 2C): broadening of the mutational spectrum guided by the immunohistochemical profile. Neuromuscul Disord 2002, 12:273-280. 10.1016/S0960-8966(01)00276-0, 11801399.
3. Ozawa E, Noguchi S, Mizuno Y, Hagiwara Y, Yoshida M. From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle & Nerve 1998, 21:421-438. 10.1002/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.0.CO;2-B, 9533777.
4. McNally EM, Duggan D, Gorospe JR, Bonnemann CG, Fanin M, Pegoraro E, Lidov HGW, Noguchi S, Ozawa E, Finkel RS, et al. Mutations that disrupt the carboxyl-terminus of g-sarcoglycan cause muscular dystrophy. Hum Mol Genet 1996, 5:1841-1847. 10.1093/hmg/5.11.1841, 8923014.
5. Guglieri M, Magri F, D'Angelo MG, Prelle A, Morandi L, Rodolico C, Cagliani R, Mora M, Fortunato F, Bordoni A, et al. Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mutat 2008, 29:258-266. 10.1002/humu.20642, 17994539.
6. Kooi AJ, Barth PG, Busch HF, de Haan R, Ginjaar HB, van Essen AJ, van Hooff LJ, Howeler CJ, Jennekens FG, Jongen P, et al. The clinical spectrum of limb girdle muscular dystrophy. A survey in The Netherlands. Brain 1996, 119:1471-1480. 10.1093/brain/119.5.1471, 8931572.
7. Emery AE. Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul Disord 1991, 1:19-29. 10.1016/0960-8966(91)90039-U, 1822774.
8. Georgieva B, Todorova A, Tournev I, Mitev V, Kremensky I. C283Y gamma-sarcoglycan gene mutation in the Bulgarian Roma (Gypsy) population: prevalence study and carrier screening in a high-risk community. Clin Genet 2004, 66:467-472. 10.1111/j.1399-0004.2004.00335.x, 15479193.
9. Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C, Brown CA, Michele DE, Piccolo F, Winder TL, et al. Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol 2006, 65:995-1003. 10.1097/01.jnen.0000235854.77716.6c, 17021404.
10. Matsuo M. Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy. Brain Dev 1996, 18:167-172. 10.1016/0387-7604(96)00007-1, 8836495.
11. Takeshima Y, Yagi M, Wada H, Ishibashi K, Nishiyama A, Kakumoto M, Sakaeda T, Saura R, Okumura K, Matsuo M. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy. Pediatr Res 2006, 59:690-694. 10.1203/01.pdr.0000215047.51278.7c, 16627883.
12. Welch EM, Barton ER, Zhuo J, Tomizawa Y, Friesen WJ, Trifills P, Paushkin S, Patel M, Trotta CR, Hwang S, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007, 447(7140):87-91. 10.1038/nature05756, 17450125.
13. Matsuo M, Masumura T, Nishio H, Nakajima T, Kitoh Y, Takumi T, Koga J, Nakamura H. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy Kobe. J Clin Invest 1991, 87:2127-2131. 10.1172/JCI115244, 296970, 2040695.
14. Tran VK, Zhang Z, Yagi M, Nishiyama A, Habara Y, Takeshima Y, Matsuo M. A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene. J Hum Genet 2005, 50:425-433. 10.1007/s10038-005-0272-6, 16133659.
15. Yagi M, Takeshima Y, Wada H, Nakamura H, Matsuo M. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy. Hum Genet 2003, 112:164-170.
16. Stec I, Kress W, Meng G, Muller B, Muller CR, Grimm T. Estimate of severe autosomal recessive limb-girdle muscular dystrophy (LGMD2C, LGMD2D) among sporadic muscular dystrophy males: a study of 415 familes. J Med Genet 1995, 32:930-933. 10.1136/jmg.32.12.930, 1051770, 8825917.
17. Vainzof M, Pavanerllo R, Pavanello-Filho I, Rapaport D, Passo-Bueno M, Zubrzycka GEE, Bulman D, Zatz M. Screening of male patients with autosomal recessive Duchenne dystrophy through dystrophin and DNA studies. Am J Med Gent 1991, 39:38-41.
18. Hayashi YK, Mizuno Y, Yoshida M, Nonaka I, Ozawa E, Arahata K. The frequency of patients with 50-kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan: immunocytochemical analysis of 50DAG, 43DAG, dystrophin, and utrophin. Neurology 1995, 45(3 Pt 1):551-554.
19. Takano A, Bonnemann CG, Honda H, Sakai M, Feener CA, Kunkel LM, Sobue G. Intrafamilial phenotypic variation in limb-girdle muscular dystrophy type 2C with compound heterozygous mutations. Muscle Nerve 2000, 23:807-810. 10.1002/(SICI)1097-4598(200005)23:5<807::AID-MUS20>3.0.CO;2-0, 10797406.
20. Klinge L, Dekomien G, Aboumousa A, Charlton R, Epplen JT, Barresi R, Bushby K, Straub V. Sarcoglycanopathies: Can muscle immunoanalysis predict the genotype?. Neuromuscul Disord 2008, 18:934-941. 10.1016/j.nmd.2008.08.003, 18996010.
21. Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci 2000, 113(Pt 14):2535-2544.
22. Vainzof M, Passos-Bueno MR, Canovas M, Moreira ES, Pavanello RCM, Marie SK, Anderson LVB, Bonnemann CG, McNally EM, Nigro V, et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996, 5:1963-1969. 10.1093/hmg/5.12.1963, 8968750.
23. Duncan DR, Kang PB, Rabbat JC, Briggs CE, Lidov HG, Darras BT, Kunkel LM. A novel mutation in two families with limb-girdle muscular dystrophy type 2C. Neurology 2006, 67:167-169. 10.1212/01.wnl.0000223600.78363.dd, 16832103.